Correction: The CEO of Oasmia buys subscription rights in the ongoing rights issue

    NEXT STORY
    Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months
    PREV STORY
    Air Idaho Rescue Partners with Eastern Idaho Regional Medical Center, Opens New Base to Service Southeastern Idaho
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    DBV Technologies Reports Full Year 2018 Financial Results and Provides Operational Update

    author_avatar
    NASDAQ Market News

    Coherus Secures Private Placement from Temasek

    REDWOOD CITY, Calif., Aug. 21, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today ...

    author_avatar
    NASDAQ Market News

    FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares

    FIT Biotech Oy Company release February 8, 2018 at 04:00 PM EET Conversion of ...

    author_avatar
    NASDAQ Market News